Leptin-receptor neurons in the dorsomedial hypothalamus regulate diurnal patterns of feeding, locomotion, and metabolism

  1. Chelsea L Faber  Is a corresponding author
  2. Jennifer D Deem
  3. Bao Anh Phan
  4. Tammy P Doan
  5. Kayoko Ogimoto
  6. Zaman Mirzadeh
  7. Michael W Schwartz
  8. Gregory J Morton  Is a corresponding author
  1. University of Washington, United States
  2. Barrow Neurological Institute, United States

Abstract

Animal behavior and metabolism are tightly coordinated with sleep-wake cycles governed by the brain in harmony with environmental light:dark cycles. Within the brain, the dorsomedial hypothalamic nucleus (DMH) has been implicated in the integrative control of feeding, energy homeostasis, and circadian rhythms,1 but the underlying cell types are unknown. Here, we identify a role for DMH leptin receptor-expressing neurons (DMHLepR) in this integrative control. Using a viral approach, we show that silencing neurotransmission in DMHLepR neurons in adult mice not only increases body weight and adiposity, but also phase-advances diurnal rhythms of feeding and metabolism into the light-cycle and abolishes the normal increase in dark-cycle locomotor activity (LMA) characteristic of nocturnal rodents. Finally, DMHLepR-silenced mice fail to entrain to a restrictive change in food availability. Together, these findings identify DMHLepR neurons as critical determinants of the daily time of feeding and associated metabolic rhythms.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1-4.

Article and author information

Author details

  1. Chelsea L Faber

    Medicine, University of Washington, Seattle, United States
    For correspondence
    kasperc@uw.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4812-8164
  2. Jennifer D Deem

    Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8865-5145
  3. Bao Anh Phan

    Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Tammy P Doan

    Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Kayoko Ogimoto

    Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Zaman Mirzadeh

    Department of Neurosurgery, Barrow Neurological Institute, Phoenix, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Michael W Schwartz

    Medicine, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1619-0331
  8. Gregory J Morton

    Medicine, University of Washington, Seattle, United States
    For correspondence
    gjmorton@uw.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8106-8386

Funding

National Institutes of Health (F31-DK113673)

  • Chelsea L Faber

American Diabetes Association (ADA 1-19-PDF-103)

  • Jennifer D Deem

U.S. Department of Defense (W81XWH2010250)

  • Zaman Mirzadeh

National Institutes of Health (DK128802)

  • Zaman Mirzadeh

National Institutes of Health (T32-GM095421)

  • Chelsea L Faber

National Institutes of Health (DK089056)

  • Gregory J Morton

National Institutes of Health (DK124238)

  • Gregory J Morton

National Institutes of Health (DK083042)

  • Michael W Schwartz

National Institutes of Health (DK101997)

  • Michael W Schwartz

National Institutes of Health (T32 DK007247)

  • Chelsea L Faber

National Institutes of Health (T32 HL007028)

  • Jennifer D Deem

American Diabetes Association (ADA 1-19-IBS-192)

  • Gregory J Morton

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Care Committee at the University of Washington. (Jackson Laboratory no. 008320)

Copyright

© 2021, Faber et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,805
    views
  • 542
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chelsea L Faber
  2. Jennifer D Deem
  3. Bao Anh Phan
  4. Tammy P Doan
  5. Kayoko Ogimoto
  6. Zaman Mirzadeh
  7. Michael W Schwartz
  8. Gregory J Morton
(2021)
Leptin-receptor neurons in the dorsomedial hypothalamus regulate diurnal patterns of feeding, locomotion, and metabolism
eLife 10:e63671.
https://doi.org/10.7554/eLife.63671

Share this article

https://doi.org/10.7554/eLife.63671

Further reading

    1. Neuroscience
    Roshani Nhuchhen Pradhan, Craig Montell, Youngseok Lee
    Research Article

    The question as to whether animals taste cholesterol taste is not resolved. This study investigates whether the fruit fly, Drosophila melanogaster, is capable of detecting cholesterol through their gustatory system. We found that flies are indifferent to low levels of cholesterol and avoid higher levels. The avoidance is mediated by gustatory receptor neurons (GRNs), demonstrating that flies can taste cholesterol. The cholesterol-responsive GRNs comprise a subset that also responds to bitter substances. Cholesterol detection depends on five ionotropic receptor (IR) family members, and disrupting any of these genes impairs the flies' ability to avoid cholesterol. Ectopic expressions of these IRs in GRNs reveals two classes of cholesterol receptors, each with three shared IRs and one unique subunit. Additionally, expressing cholesterol receptors in sugar-responsive GRNs confers attraction to cholesterol. This study reveals that flies can taste cholesterol, and that the detection depends on IRs in GRNs.

    1. Neuroscience
    Poortata Lalwani, Thad Polk, Douglas D Garrett
    Research Article

    Moment-to-moment neural variability has been shown to scale positively with the complexity of stimulus input. However, the mechanisms underlying the ability to align variability to input complexity are unknown. Using a combination of behavioral methods, computational modeling, fMRI, MR spectroscopy, and pharmacological intervention, we investigated the role of aging and GABA in neural variability during visual processing. We replicated previous findings that participants expressed higher variability when viewing more complex visual stimuli. Additionally, we found that such variability modulation was associated with higher baseline visual GABA levels and was reduced in older adults. When pharmacologically increasing GABA activity, we found that participants with lower baseline GABA levels showed a drug-related increase in variability modulation while participants with higher baseline GABA showed no change or even a reduction, consistent with an inverted-U account. Finally, higher baseline GABA and variability modulation were jointly associated with better visual-discrimination performance. These results suggest that GABA plays an important role in how humans utilize neural variability to adapt to the complexity of the visual world.